These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 15646418)
21. Clinicopathologic features of patients with intrahepatic cholangiocarcinoma who are seropositive for alpha-fetoprotein-L3 and those with combined hepatocellular and cholangiocarcinoma. Okuda H; Shiratori K; Yamamoto M; Takasaki K; Nakano M J Gastroenterol Hepatol; 2006 May; 21(5):869-73. PubMed ID: 16704538 [TBL] [Abstract][Full Text] [Related]
22. Clinicopathological characteristics of 15 patients with combined hepatocellular carcinoma and cholangiocarcinoma. Zuo HQ; Yan LN; Zeng Y; Yang JY; Luo HZ; Liu JW; Zhou LX Hepatobiliary Pancreat Dis Int; 2007 Apr; 6(2):161-5. PubMed ID: 17374575 [TBL] [Abstract][Full Text] [Related]
23. [A case of sarcomatoid combined hepatocellular-cholangiocarcinoma]. Jeong BJ; Hyun DH; Lee KW; Ryu ST; Lee JW; Lee JI; Jeong S; Lee DH; Kim PS; Kim HG; Kim YS; Kim JM Korean J Gastroenterol; 2004 Jan; 43(1):56-60. PubMed ID: 14745254 [TBL] [Abstract][Full Text] [Related]
24. Comparison of combined hepatocellular and cholangiocarcinoma with hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Lee WS; Lee KW; Heo JS; Kim SJ; Choi SH; Kim YI; Joh JW Surg Today; 2006; 36(10):892-7. PubMed ID: 16998683 [TBL] [Abstract][Full Text] [Related]
26. State-of-the-art MR Imaging of Uncommon Hepatocellular Tumours: Fibrolamellar Hepatocellular Carcinoma and Combined Hepatocellularcholangiocarcinoma. Anysz-Grodzicka A; Podgorska J; Cieszanowski A Curr Med Imaging Rev; 2019; 15(3):269-280. PubMed ID: 31989878 [TBL] [Abstract][Full Text] [Related]
27. Use of 18F-FDG PET Scan and Ultrasound-guided Biopsy in the Diagnosis of Hepatic Carcinomas. Shao H; Cheng W; Yu L; Li Y; Jing H Hepatogastroenterology; 2015 Jun; 62(140):978-81. PubMed ID: 26902040 [TBL] [Abstract][Full Text] [Related]
28. Mutational landscape of combined hepatocellular carcinoma and cholangiocarcinoma, and its clinicopathological significance. Sasaki M; Sato Y; Nakanuma Y Histopathology; 2017 Feb; 70(3):423-434. PubMed ID: 27634656 [TBL] [Abstract][Full Text] [Related]
29. Double primary hepatic cancer (hepatocellular carcinoma and intrahepatic cholangiocarcinoma) originating from hepatic progenitor cell: a case report and review of the literature. Hu J; Yuan R; Huang C; Shao J; Zou S; Wang K World J Surg Oncol; 2016 Aug; 14(1):218. PubMed ID: 27535234 [TBL] [Abstract][Full Text] [Related]
30. A clinicopathological study on combined hepatocellular and cholangiocarcinoma. Taguchi J; Nakashima O; Tanaka M; Hisaka T; Takazawa T; Kojiro M J Gastroenterol Hepatol; 1996 Aug; 11(8):758-64. PubMed ID: 8872774 [TBL] [Abstract][Full Text] [Related]
31. Combined hepatocellular and cholangiocellular carcinoma in a non-cirrhotic liver. Shiraishi M; Takushi Y; Simoji H; Oshiro T; Shinzato S; Tanigawa N; Kusano T; Muto Y J Gastroenterol; 1998 Aug; 33(4):593-6. PubMed ID: 9719250 [TBL] [Abstract][Full Text] [Related]
32. Occurrence of hepatocellular and cholangiocellular carcinoma in different hepatic lobes. Ito Y; Fujioka H; Matsuzaki S; Yamamoto O; Okudaira S; Azuma T; Furui J; Kanematsu T Hepatogastroenterology; 2003; 50(49):65-8. PubMed ID: 12629992 [TBL] [Abstract][Full Text] [Related]
33. Synchronous liver cancers: A rare tumor combination in an elderly Japanese woman. Shigaki DM; Nekoba AC; Ide JY; Hardman JM; Tokeshi J Hawaii Med J; 2006 Jun; 65(6):166-7, 178. PubMed ID: 16895268 [TBL] [Abstract][Full Text] [Related]
34. A case with intrahepatic double cancer: hepatocellular carcinoma and cholangiocarcinoma associated with multiple von Meyenburg complexes. Kim YW; Park YK; Park JH; Lee J; Lee SM; Hong SW; Yang MH Yonsei Med J; 1999 Oct; 40(5):506-9. PubMed ID: 10565264 [TBL] [Abstract][Full Text] [Related]
35. [Failure factors of guided puncture of hepatic masses]. Taourel P; Benkirane K; Barnéon G; Larrey D; Blanc F; Pradel J; Michel H; Bruel JM Gastroenterol Clin Biol; 1993; 17(12):892-6. PubMed ID: 8125220 [TBL] [Abstract][Full Text] [Related]
36. The alphavbeta6 integrin is a highly specific immunohistochemical marker for cholangiocarcinoma. Patsenker E; Wilkens L; Banz V; Osterreicher CH; Weimann R; Eisele S; Keogh A; Stroka D; Zimmermann A; Stickel F J Hepatol; 2010 Mar; 52(3):362-9. PubMed ID: 20137822 [TBL] [Abstract][Full Text] [Related]
37. Combined hepatocellular and cholangiocellular carcinoma. Murakami T; Kim T; Tomoda K; Narumi Y; Sakon M; Wakasa K; Nakamura H Radiat Med; 1997; 15(4):243-6. PubMed ID: 9311042 [TBL] [Abstract][Full Text] [Related]
38. Impact of incidental/misdiagnosed intrahepatic cholangiocarcinoma and combined hepatocellular cholangiocarcinoma on the outcomes of liver transplantation: an institutional case series and literature review. Gupta R; Togashi J; Akamatsu N; Sakamoto Y; Kokudo N Surg Today; 2017 Aug; 47(8):908-917. PubMed ID: 28124125 [TBL] [Abstract][Full Text] [Related]